Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.

2.50
Hdl Handle:
http://hdl.handle.net/10033/621101
Title:
Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.
Authors:
Thöne, Kathrin; Horn, Johannes; Mikolajczyk, Rafael T ( 0000-0003-1271-7204 )
Abstract:
Shortly after the human papillomavirus (HPV) vaccine recommendation and hence the reimbursement of vaccination costs for the respective age groups in Germany in 2007, changes in the incidence of anogenital warts (AGWs) were observed, but it was not clear at what level the incidence would stabilize and to what extent herd immunity would be present. Given the relatively low HPV vaccination coverage in Germany, we aimed to assess potential vaccination herd immunity effects in the German setting.
Affiliation:
Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.
Citation:
Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data. 2017, 17 (1):564 BMC Infect. Dis.
Journal:
BMC infectious diseases
Issue Date:
14-Aug-2017
URI:
http://hdl.handle.net/10033/621101
DOI:
10.1186/s12879-017-2663-7
PubMed ID:
28806926
Type:
Article
Language:
en
ISSN:
1471-2334
Appears in Collections:
Publications of the AG (ESME)

Full metadata record

DC FieldValue Language
dc.contributor.authorThöne, Kathrinen
dc.contributor.authorHorn, Johannesen
dc.contributor.authorMikolajczyk, Rafael Ten
dc.date.accessioned2017-09-11T11:46:45Z-
dc.date.available2017-09-11T11:46:45Z-
dc.date.issued2017-08-14-
dc.identifier.citationEvaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data. 2017, 17 (1):564 BMC Infect. Dis.en
dc.identifier.issn1471-2334-
dc.identifier.pmid28806926-
dc.identifier.doi10.1186/s12879-017-2663-7-
dc.identifier.urihttp://hdl.handle.net/10033/621101-
dc.description.abstractShortly after the human papillomavirus (HPV) vaccine recommendation and hence the reimbursement of vaccination costs for the respective age groups in Germany in 2007, changes in the incidence of anogenital warts (AGWs) were observed, but it was not clear at what level the incidence would stabilize and to what extent herd immunity would be present. Given the relatively low HPV vaccination coverage in Germany, we aimed to assess potential vaccination herd immunity effects in the German setting.en
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleEvaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.en
dc.typeArticleen
dc.contributor.departmentHelmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.en
dc.identifier.journalBMC infectious diseasesen

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.